Amedisys, Inc. (NASDAQ: AMED) reported Q1 EPS of ($0.07), $0.03 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $298.74 million versus the consensus estimate of $301.89 million.

For earnings history and earnings-related data on Amedisys, Inc. (AMED) click here.